0001171843-18-003058.txt : 20180425 0001171843-18-003058.hdr.sgml : 20180425 20180425165829 ACCESSION NUMBER: 0001171843-18-003058 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180425 FILED AS OF DATE: 20180425 DATE AS OF CHANGE: 20180425 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Katz Richard D CENTRAL INDEX KEY: 0001293577 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35443 FILM NUMBER: 18775009 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 300 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001105533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562110007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 BUSINESS PHONE: 9192876300 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 FORMER COMPANY: FORMER CONFORMED NAME: MERIX BIOSCIENCE INC DATE OF NAME CHANGE: 20000207 4 1 formfour.xml OWNERSHIP DOCUMENT X0306 4 2018-04-25 0 0001105533 ARGOS THERAPEUTICS INC ARGS 0001293577 Katz Richard D 4505 EMPEROR BOULEVARD, SUITE 300 DURHAM NC 27703 0 1 0 0 Vice President and CFO Common Stock 2018-04-25 4 D 0 22629 0 D 9697 D Represents shares forfeited upon the delisting of the Company's common stock from The Nasdaq Capital Market. /s/ Lori R. Harrelson, attorney in fact 2018-04-25